{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "marketState": "REGULAR", "regularMarketChangePercent": 3.4090943, "regularMarketPrice": 3.64, "exchange": "STO", "shortName": "Elicera Therapeutics AB", "longName": "Elicera Therapeutics AB (publ)", "messageBoardId": "finmb_699501886", "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "se_market", "esgPopulated": false, "regularMarketTime": 1684143297, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.98, "sharesOutstanding": 19782000, "bookValue": 1.658, "fiftyDayAverage": 3.6526, "fiftyDayAverageChange": -0.012599945, "fiftyDayAverageChangePercent": -0.0034495825, "twoHundredDayAverage": 3.944575, "twoHundredDayAverageChange": -0.30457497, "twoHundredDayAverageChangePercent": -0.07721363, "marketCap": 72415616, "priceToBook": 2.1954162, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Elicera Therapeutics AB", "nameChangeDate": "2023-05-14", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1623394800000, "priceHint": 4, "regularMarketChange": 0.120000124, "regularMarketDayHigh": 3.84, "regularMarketDayRange": "3.46 - 3.84", "regularMarketDayLow": 3.46, "regularMarketVolume": 6168, "regularMarketPreviousClose": 3.52, "bid": 3.52, "ask": 3.64, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 3.54, "averageDailyVolume3Month": 16789, "averageDailyVolume10Day": 21047, "fiftyTwoWeekLowChange": 0.34000015, "fiftyTwoWeekLowChangePercent": 0.103030354, "fiftyTwoWeekRange": "3.3 - 5.49", "fiftyTwoWeekHighChange": -1.8499997, "fiftyTwoWeekHighChangePercent": -0.33697626, "fiftyTwoWeekLow": 3.3, "fiftyTwoWeekHigh": 5.49, "symbol": "ELIC.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "World Trade Centre Gothenburg", "address2": "Floor 7 M\u00e4ssans gata 10", "city": "Gothenburg", "zip": "412 51", "country": "Sweden", "phone": "46 7 03 31 90 51", "website": "https://www.elicera.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Elicera Therapeutics AB (publ), a clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio products in pipeline includes ELC-100, a Phase I/II drug candidate for neuroendocrine tumors indications; ELC-201, a preclinical drug candidate for the treatment of various injectable solid tumors; ELC-301, a CAR T-cell therapy for the treatment of Non-Hodgkin's B-cell lymphoma; and ELC-401, a preclinical drug candidate glioblastoma multiforme (brain tumor) indications. It also develops iTANK, a technology platform used to optimize the effect of various CAR T-cell therapies for the multi-targeted attack on solid tumors. The company was incorporated in 2014 and is based in Gothenburg, Sweden.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jamal  El-Mosleh M.Sc.", "age": 41, "title": "CEO & Co-Founder", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Magnus  Essand", "age": 58, "title": "Chief Science Officer, Co-Founder & Director", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Di  Yu", "age": 37, "title": "Co-Founder and Head of Transitional Research & Technical Operations", "yearBorn": 1985, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ingvar  Karlsson", "age": 66, "title": "Chief Financial Officer", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anna Koptina Gultekin", "title": "Head of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}